Karriereverlauf von Sarah DiSalvatore
Ehemalige bekannte Positionen von Sarah DiSalvatore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 | 01.04.2023 |
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
- Börse
- Insiders
- Sarah DiSalvatore
- Erfahrung
